An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21
Abstract Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) when VZV-specific cellular immunity is insufficient to control reactivation. Currently, Shingrix, which contains the VZV gE protein and GSK’s AS01B adjuvant composed of liposomes formulated with cholesterol,...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Portfolio
2022-04-01
|
| Reeks: | npj Vaccines |
| Online toegang: | https://doi.org/10.1038/s41541-022-00467-z |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|